DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model

BACKGROUND: There is a significant demand for colorectal cancer (CRC) screening methods that are noninvasive, inexpensive, and capable of accurately detecting early stage tumors. It has been shown that models based on the gut microbiota can complement the fecal occult blood test and fecal immunochem...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Nielson T., Koumpouras, Charles C., Rogers, Mary A. M., Ruffin, Mack T., Schloss, Patrick D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109736/
https://www.ncbi.nlm.nih.gov/pubmed/27842559
http://dx.doi.org/10.1186/s40168-016-0205-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109736/
https://www.ncbi.nlm.nih.gov/pubmed/27842559
http://dx.doi.org/10.1186/s40168-016-0205-y

Ejemplares similares